Skip to main content
Full access
Regular Articles
Published Online: 1 January 2012

Longitudinal Evaluation of Neuropsychiatric Symptoms in Huntington's Disease

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences

Abstract

A group of 111 patients with Huntington's disease (HD) underwent a minimum of three annual neuropsychiatric assessments, using the Problem Behaviors Assessment for Huntington's Disease (PBA-HD). Longitudinal prevalence of neuropsychiatric symptoms was notably higher than baseline prevalence, suggesting that previous studies may have underestimated the extent of this clinical problem. Moreover, apathy, irritability, and depression were each associated with distinct longitudinal profiles. Apathy progressed over time and across disease stages. Irritability also increased significantly, but only in early stages of HD. Depression did not increase significantly at any stage of disease. The neuropsychiatric syndrome of apathy appears to be intrinsic to the evolution and progression of HD.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 53 - 60
PubMed: 22450614

History

Received: 2 March 2011
Revision requested: 29 July 2011
Accepted: 16 August 2011
Published online: 1 January 2012
Published in print: Winter 2012

Keywords

  1. Huntington's Disease
  2. Neuropsychiatric Symptoms
  3. Longitudinal Evaluation
  4. Apathy
  5. Irritability
  6. Depression

Authors

Affiliations

Jennifer C. Thompson, Ph.D.
From the Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust, Salford, UK; Neurodegeneration and Mental Health Research Group, School of Community-Based Medicine, University of Manchester, Manchester, UK; Genetic Medicine, Manchester Academic Health Sciences Centre, University of Manchester and St. Mary's Hospital, Central Manchester University Hospitals Foundation NHS Trust, Manchester, UK.
Jenny Harris, B.Sc.
From the Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust, Salford, UK; Neurodegeneration and Mental Health Research Group, School of Community-Based Medicine, University of Manchester, Manchester, UK; Genetic Medicine, Manchester Academic Health Sciences Centre, University of Manchester and St. Mary's Hospital, Central Manchester University Hospitals Foundation NHS Trust, Manchester, UK.
Andrea C. Sollom, M.A.
From the Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust, Salford, UK; Neurodegeneration and Mental Health Research Group, School of Community-Based Medicine, University of Manchester, Manchester, UK; Genetic Medicine, Manchester Academic Health Sciences Centre, University of Manchester and St. Mary's Hospital, Central Manchester University Hospitals Foundation NHS Trust, Manchester, UK.
Cheryl L. Stopford, Ph.D.
From the Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust, Salford, UK; Neurodegeneration and Mental Health Research Group, School of Community-Based Medicine, University of Manchester, Manchester, UK; Genetic Medicine, Manchester Academic Health Sciences Centre, University of Manchester and St. Mary's Hospital, Central Manchester University Hospitals Foundation NHS Trust, Manchester, UK.
Elizabeth Howard, MBChB
From the Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust, Salford, UK; Neurodegeneration and Mental Health Research Group, School of Community-Based Medicine, University of Manchester, Manchester, UK; Genetic Medicine, Manchester Academic Health Sciences Centre, University of Manchester and St. Mary's Hospital, Central Manchester University Hospitals Foundation NHS Trust, Manchester, UK.
Julie S. Snowden, Ph.D.
From the Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust, Salford, UK; Neurodegeneration and Mental Health Research Group, School of Community-Based Medicine, University of Manchester, Manchester, UK; Genetic Medicine, Manchester Academic Health Sciences Centre, University of Manchester and St. Mary's Hospital, Central Manchester University Hospitals Foundation NHS Trust, Manchester, UK.
David Craufurd, M.Sc.
From the Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust, Salford, UK; Neurodegeneration and Mental Health Research Group, School of Community-Based Medicine, University of Manchester, Manchester, UK; Genetic Medicine, Manchester Academic Health Sciences Centre, University of Manchester and St. Mary's Hospital, Central Manchester University Hospitals Foundation NHS Trust, Manchester, UK.

Notes

Correspondence: Dr. Jennifer Thompson, Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust; [email protected] (e-mail).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share